Clinical Trials Search

Search ALL Clinical Trials at GBMC 
 

Oncology-Head and Neck 

Title Study Number Trial Type Condition Trial Status Principal Investigator
A Phase II Trial of Tadalafil in Patients with Squamous Cell Carcinoma of the Upper Aero Digestive Tract 12-057-10  Oncology-Head and Neck    Open to Accrual  Joseph Califano¸ MD 
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Center R0920  Oncology-Head and Neck    Open to Accrual  Marshall Levine¸ MD 
A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients With Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence E1311  Oncology-Head and Neck    Open to Accrual  Marshall Levine¸ MD 
Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck R1216  Oncology-Head and Neck    Open to Accrual  Marshall Levine¸ MD 
A Retrospective Review of Chemoradiation Treatment Protocols for Head and Neck Cancer Patients. HN1001  Oncology-Head and Neck    Open to Accrual  Patrick Ha¸ MD 
Non·Oropharyngeal Robotic Surgery for Head and Neck Lesions
NORS/BLANCO  Oncology-Head and Neck    Open to Accrual  Ray Gervacio F. Blanco¸ MD 
Detection of Genetic Alterations in Head and Neck Tumors. HN0801  Oncology-Head and Neck  Open to Accrual  Joseph Califano¸ MD 
Molecular Surveillance for Head and Neck Cancer. HN0902  Oncology-Head and Neck  Open to Accrual  Joseph Califano¸ MD 
A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent Or Metastatic Head and Neck Cancer E1305  Oncology-Head and Neck  Open to Accrual  Marshall Levine¸ MD 
Collection of Waste Tissue from Surgically Resected Human Head and Neck Neoplasms for Xenografting in Athymic or SCID Mice. HN0701  Oncology-Head and Neck  Open to Accrual  Patrick Ha¸ MD 
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma R1010  Oncology-Head and Neck  Esophageal  Open to Accrual  Marshall Levine¸ MD 
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer E3311  Oncology-Head and Neck  Oropharynx  Open to Accrual  Marshall Levine¸ MD 
A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
R1008  Oncology-Head and Neck  Salivary Gland  Open to Accrual  Marshall Levine¸ MD 
Greater Baltimore Medical Center | 6701 North Charles Street | Baltimore, MD 21204 | (443) 849-2000 | TTY (800) 735-2258
© 2014  GBMC. This website is for informational purposes only and not intended as medical advice or a substitute for a consultation with a professional healthcare provider.